98 related articles for article (PubMed ID: 34638235)
1. Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort Study.
Benderra MA; Aparicio A; Leblanc J; Wassermann D; Kempf E; Galula G; Bernaux M; Canellas A; Moreau T; Bellamine A; Spano JP; Daniel C; Champ J; Canouï-Poitrine F; Gligorov J; On Behalf Of The Ap-Hp/Universities/Inserm Covid-Research Collaboration ; Cancer Ap-Hp Group Covid-Task Force ; Ap-Hp Covid Cdw Initiative Acci
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638235
[TBL] [Abstract][Full Text] [Related]
2. In-hospital mortality and severe outcomes after hospital discharge due to COVID-19: A prospective multicenter study from Brazil.
Perazzo H; Cardoso SW; Ribeiro MPD; Moreira R; Coelho LE; Jalil EM; Japiassú AM; Gouvêa EP; Nunes EP; Andrade HB; Gouvêa LB; Ferreira MT; Rodrigues PMA; Moreira R; Geraldo K; Freitas L; Pacheco VV; João EC; Fuller T; Rocha VD; Nunes CLX; Souza TNL; Toscano ALCC; Schwarzbold AV; Noal HC; Pinto GA; Lemos PMO; Santos C; Mello FCQ; Veloso VG; Grinsztejn B;
Lancet Reg Health Am; 2022 Jul; 11():100244. PubMed ID: 35434696
[TBL] [Abstract][Full Text] [Related]
3. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
[TBL] [Abstract][Full Text] [Related]
4. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study.
Giacomelli A; Ridolfo AL; Milazzo L; Oreni L; Bernacchia D; Siano M; Bonazzetti C; Covizzi A; Schiuma M; Passerini M; Piscaglia M; Coen M; Gubertini G; Rizzardini G; Cogliati C; Brambilla AM; Colombo R; Castelli A; Rech R; Riva A; Torre A; Meroni L; Rusconi S; Antinori S; Galli M
Pharmacol Res; 2020 Aug; 158():104931. PubMed ID: 32446978
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the prevalence of new-onset musculoskeletal symptoms in patients hospitalized for severe SARS-CoV-2 infection during the first two COVID waves in France: A descriptive analysis of the clinical data warehouse of 39 hospitals in France.
Molto A; Pinson P; Beeker N; Roux C
Joint Bone Spine; 2022 Nov; 89(6):105450. PubMed ID: 35944597
[TBL] [Abstract][Full Text] [Related]
6. Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy.
Mirani M; Favacchio G; Carrone F; Betella N; Biamonte E; Morenghi E; Mazziotti G; Lania AG
Diabetes Care; 2020 Dec; 43(12):3042-3049. PubMed ID: 33023989
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the demographic characteristics and comorbidities of patients with COVID-19 who died in Spanish hospitals based on whether they were or were not admitted to an intensive care unit.
Miró Ò; Alquézar-Arbé A; Llorens P; Martín-Sánchez FJ; Jiménez S; Martín A; Burillo-Putze G; Jacob J; García-Lamberechts EJ; Piñera P; Del Castillo JG;
Med Intensiva (Engl Ed); 2021; 45(1):14-26. PubMed ID: 33158594
[TBL] [Abstract][Full Text] [Related]
8. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
[TBL] [Abstract][Full Text] [Related]
10. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis.
Salter A; Fox RJ; Newsome SD; Halper J; Li DKB; Kanellis P; Costello K; Bebo B; Rammohan K; Cutter GR; Cross AH
JAMA Neurol; 2021 Jun; 78(6):699-708. PubMed ID: 33739362
[TBL] [Abstract][Full Text] [Related]
12. High risk groups for severe COVID-19 in a whole of population cohort in Australia.
Liu B; Spokes P; He W; Kaldor J
BMC Infect Dis; 2021 Jul; 21(1):685. PubMed ID: 34266396
[TBL] [Abstract][Full Text] [Related]
13. Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.
Mah J; Lieu A; Palayew M; Alipour P; Kong LY; Song S; Palayew A; Tutt-Guérette MA; Yang SS; Wilchesky M; Lipes J; Azoulay L; Greenaway C
CMAJ Open; 2021; 9(3):E718-E727. PubMed ID: 34257090
[TBL] [Abstract][Full Text] [Related]
14. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area.
Vuagnat P; Frelaut M; Ramtohul T; Basse C; Diakite S; Noret A; Bellesoeur A; Servois V; Hequet D; Laas E; Kirova Y; Cabel L; Pierga JY; ; Bozec L; Paoletti X; Cottu P; Bidard FC
Breast Cancer Res; 2020 May; 22(1):55. PubMed ID: 32460829
[TBL] [Abstract][Full Text] [Related]
16. COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection: a population-based cohort stuJune 2020.dy in Southern Catalonia, Spain, March-.
Vila-Corcoles A; Satue-Gracia E; Vila-Rovira A; de Diego-Cabanes C; Forcadell-Peris MJ; Hospital-Guardiola I; Ochoa-Gondar O; Basora-Gallisa J
BMC Public Health; 2021 Oct; 21(1):1795. PubMed ID: 34615512
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain.
Ramos-Rincon JM; Buonaiuto V; Ricci M; Martín-Carmona J; Paredes-Ruíz D; Calderón-Moreno M; Rubio-Rivas M; Beato-Pérez JL; Arnalich-Fernández F; Monge-Monge D; Vargas-Núñez JA; Acebes-Repiso G; Mendez-Bailon M; Perales-Fraile I; García-García GM; Guisado-Vasco P; Abdelhady-Kishta A; Pascual-Pérez MD; Rodríguez-Fernández-Viagas C; Montaño-Martínez A; López-Ruiz A; Gonzalez-Juarez MJ; Pérez-García C; Casas-Rojo JM; Gómez-Huelgas R;
J Gerontol A Biol Sci Med Sci; 2021 Feb; 76(3):e28-e37. PubMed ID: 33103720
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
[TBL] [Abstract][Full Text] [Related]
19. Long-term mortality following SARS-CoV-2 infection: A national cohort study from Estonia.
Uusküla A; Jürgenson T; Pisarev H; Kolde R; Meister T; Tisler A; Suija K; Kalda R; Piirsoo M; Fischer K
Lancet Reg Health Eur; 2022 Jul; 18():100394. PubMed ID: 35505834
[TBL] [Abstract][Full Text] [Related]
20. Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study.
Hoertel N; Rezaei K; Sánchez-Rico M; Delgado-Álvarez A; Kornhuber J; Gulbins E; Olfson M; Ouazana-Vedrines C; Carpinteiro A; Cougoule C; Becker KA; Alvarado JM; Limosin F; On Behalf Of The Ap-Hp/Université Paris Cité/Inserm Covid-Research Collaboration Ap-Hp Covid Cdr Initiative And Entrepôt de Données de Santé Ap-Hp Consortium
Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
